ENT Diagnostic Devices Market Progress & Manufacturer Contribution Highlighted until 2028

Kategorie der Pressemeldung: 
Mitteilung: 

An up-to-date research report has been disclosed by FactMR highlighting the titled “ENT Diagnostic Devices Market Progress & Manufacturer Contribution Highlighted until 2028” which delivers an outlook of current market value as well as the expected forecast including Rate on Investment (ROI) together with growing CAGR during 2018-2028. The report studies the ENT Diagnostic Devices Market worldwide, especially in North America, Europe, Southeast Asia, India and Other Regions with production, size, growth, revenue, consumption, import and export in these regions.

Get 100 Page Sample Report here – https://www.factmr.com/connectus/sample?flag=S&rep_id=2468

FactMR report delivers information on notable developments of all the key players in the ENT diagnostic devices market. Profiled players in the ENT diagnostic devices market includes Karl Storz GmbH & Co KG, BioMed Jena GmbH, MAICO Diagnostics GmbH, PATH medical GmbH, Fujifilm Corporation, Smith and Nephew PLC., Hedera Biomedics S.r.l., iHEARmedical, Inc., Hill-Rom., Veran Medical Technologies and Ambu A/S among others.

Top 5 Players Hold 56% of ENT Diagnostic Devices Market Revenues

The ENT diagnostic devices market remains moderately consolidated among top 5 players who hold over half the market share. Top 5 players in the ENT diagnostic devices market are Medtronic Plc, Fujifilm Corporation, Smith and Nephew Plc., Stryker Corporation and Natus Medical Incorporated. Mergers and acquisitions are the prominent growth strategies adopted by these players. In addition, R&D collaborations are also prominent to lower the prices of ENT diagnostic devices.

The ENT diagnostic devices market is also witnessing the emergence of local start-ups who are introducing low-priced devices. Owing to the successful penetration of these devices, the start-ups and small players have increased manufacturing capacities as well as regional market presence. Increasing revenues of these companies are challenging the hegemony of leading players in the ENT diagnostic devices market.

Focus on Care Delivery Introduces Breakthrough Innovations in ENT Diagnostic Devices Landscape

As the medtech industry has shifted from marketing model to a care delivery model, greater strides are underway in the field of the medical diagnostic technology landscape. In a bid to introduce improved diagnosis, the ENT diagnostic devices marketplace has witnessed the introduction of multiple breakthrough innovations.

View This Full Report with TOC, Click Here – https://www.factmr.com/report/2468/ent-diagnostic-devices-market

Telemedicine is a phenomenon in the otolaryngology which brings medical care to patients. Although, otolaryngology has witnessed slower adoption of telemedicine, advances in audiograms, diagnostic imaging and endoscopy have increased use of telemedicine approach. Further, to bridge the gap between patient and point of care, ENT diagnostic devices market is witnessing the introduction of smart devices. For instance, after Cupris Health’s introduction of smartphone otoscope in January 2018, in May 2018, hearX Group introduced the world’s first clinically validated smartphone audiometry solution hear Test.

Problems associated with ear, nose and throat are among the most common factors responsible for hospital visits, particularly among the pediatric population. The ageing population has further increased the number of hospital visits for ENT problems across the globe. According to a survey study by Massachusetts Eye and Ear Infirmary, prevalence of tinnitus was found to be between 8 to 25.3% of the population of the United States. Between 10 to 30% of the population in the United States and Europe is affected by Sinusitis.

Advances in the accessibility of healthcare facilities and favorable reimbursement policies for ENT procedures have increased the number of ENT surgeries performed for the treatment of ENT related diseases. Prevalence of ENT disorders and rising penetration of ENT surgeries are expected to increase the importance of ENT diagnostic devices in the future.

High Cost of the ENT Diagnostic Devices to Hamper Market Growth

Acquiring an ENT diagnostic device involves an initial capital investment of device purchase and set up, and further cost of repair and maintenance. The cost recovery depends on uncertain factors such as the number of procedures performed per day. Further, limited financial support in specific locations impedes the adoption of improved ENT diagnostic devices in the healthcare facilities.